BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 21348250)

  • 41. ABO blood group discrepancies among blood donors in Regional Blood Transfusion Centre GTB Hospital, Delhi, India.
    Sharma T; Garg N; Singh B
    Transfus Apher Sci; 2014 Feb; 50(1):75-80. PubMed ID: 24314713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunological safety of blood transfusions. Present state of the problem (author's transl)].
    Habibi B
    Anesth Analg (Paris); 1981; 38(5-6):243-51. PubMed ID: 7270940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ABO-incompatible blood transfusion and invasive therapeutic approaches during pediatric cardiopulmonary bypass.
    Aliç Y; Akpek EA; Dönmez A; Ozkan S; Perfusionist GY; Aslamaci S
    Anesth Analg; 2008 Oct; 107(4):1185-7. PubMed ID: 18806026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Donor-type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant.
    Quek J; Lee JJ; Lim FL; Diong C; Goh YT; Gopalakrishnan S; Ho A; Hwang W; Koh M; Loh Y; Linn YC
    Transfusion; 2019 Jan; 59(1):335-339. PubMed ID: 30467850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessing the risks of haemolysis as an adverse reaction following the transfusion of ABO incompatible plasma-containing components - A scoping review.
    McCullagh J; Cardigan R; Brunskill SJ; Bullock T; Doree C; Estcourt L; Huish S; Sandercock J; Green L
    Blood Rev; 2022 Nov; 56():100989. PubMed ID: 35871104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ABO incompatible transfusions--experience from the UK Serious Hazards of Transfusion (SHOT) scheme Transfusions ABO incompatible.
    Stainsby D
    Transfus Clin Biol; 2005 Nov; 12(5):385-8. PubMed ID: 16325447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma exchange in acute hemolytic reaction due to ABO-incompatible erythrocyte concentrate transfusions: Single center experience.
    Andıç N; Teke HÜ; Gündüz E
    Transfus Med; 2023 Oct; 33(5):409-412. PubMed ID: 37379860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of two platelet transfusion strategies to minimize ABO-nonidentical transfusion, outdating, and shortages using a computer-simulated "virtual blood bank".
    Jackups R; Kymes S
    Transfusion; 2015 Feb; 55(2):348-56. PubMed ID: 25178153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of ABO incompatibility on engraftment and transfusion requirement after unrelated cord blood transplantation: a single institute experience in Japan.
    Tomonari A; Takahashi S; Ooi J; Tsukada N; Konuma T; Kobayashi T; Sato A; Iseki T; Yamaguchi T; Tojo A; Asano S
    Bone Marrow Transplant; 2007 Sep; 40(6):523-8. PubMed ID: 17646845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dilution is not the solution: acute hemolytic transfusion reaction after ABO-incompatible pooled platelet transfusion.
    Guarente J; Harach M; Gould J; Karp JK; Peedin AR
    Immunohematology; 2019 Sep; 35(3):91-94. PubMed ID: 31621366
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
    Rowley SD; Liang PS; Ulz L
    Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Erythropoietin in the treatment of delayed immune hemolysis of a major ABO-incompatible bone marrow transplant.
    López J; Steegmann JL; Pérez G; Otero MJ; Berberana M; Cámara R; Lamana M; Fernández Villalta MJ; Fernández-Rañada JM
    Am J Hematol; 1994 Mar; 45(3):237-9. PubMed ID: 8296795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical guide to ABO-incompatible allogeneic stem cell transplantation.
    Booth GS; Gehrie EA; Bolan CD; Savani BN
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1152-8. PubMed ID: 23571461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravascular hemolysis secondary to ABO incompatible platelet products. An underrecognized transfusion reaction.
    McManigal S; Sims KL
    Am J Clin Pathol; 1999 Feb; 111(2):202-6. PubMed ID: 9930141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemolysis following platelet transfusions from ABO-incompatible donors.
    Pierce RN; Reich LM; Mayer K
    Transfusion; 1985; 25(1):60-2. PubMed ID: 2578692
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning.
    Canals C; Muñiz-Díaz E; Martínez C; Martino R; Moreno I; Ramos A; Arilla M; Boto N; Pastoret C; Remacha A; Sierra J; Madoz P
    Transfusion; 2004 Nov; 44(11):1603-11. PubMed ID: 15504166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preventing Mistransfusions: An Evaluation of Institutional Knowledge and a Response.
    MacDougall N; Dong F; Broussard L; Comunale ME
    Anesth Analg; 2018 Jan; 126(1):247-251. PubMed ID: 28930939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ABO identical versus ABO compatible plasma transfusions.
    Taraldsrud E; Kjollesdal KS; Pripp AH; Solheim BG
    Vox Sang; 2012 Aug; 103(2):177-8. PubMed ID: 22348252
    [No Abstract]   [Full Text] [Related]  

  • 59. [Blood Transfusion Inspection].
    Ide D
    Rinsho Byori; 2017 Mar; 65(3):345-350. PubMed ID: 30802022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinically significant anti-A(1) in a presumed ABO-identical hematopoietic stem cell transplant recipient: a case report.
    Jaben EA; Jacob EK; Tauscher C; D'Souza A; Hogan WJ; Stubbs JR
    Transfusion; 2013 Jan; 53(1):202-5. PubMed ID: 22574682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.